G. Montalescot's scientific contributions

Publications (2)

Article
Pretreatment with prasugrel at the time of diagnosis of non-ST-segment elevation acute coronary syndromes, rather than at the time of percutaneous intervention, did not reduce ischemic events and increased bleeding, according to results from A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pretreatment at the Time o...
Article
Early administration of eplerenone added to standard treatment in postmyocardial infarction patients appears to reduce the risk of adverse cardiovascular outcomes and heart failure, according to results from the Impact of Eplerenone on Cardiovascular Outcomes in Patients Post-Myocardial Infarction trial [REMINDER; NCT01176968].